ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma||Baylor College of Medicine / Meenakshi Hegde, MD||'A' Award Grants||2016||Texas|
|Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.||Baylor College of Medicine / Eveline Barbieri, MD, PhD||Young Investigator Grants||2008||Texas|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|Genetic Analysis of Pediatric Gliomas||Baylor College of Medicine / Will Parsons, MD, PhD||'A' Award Grants||2009||Texas|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|
|Mediators of Metastasis in Alveolar Rhabdomyosarcoma.||University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD||Young Investigator Grants||2006||Texas|
|Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.||Huntsman Cancer Institute / Stephen Lessnick||Innovation Grants||2009||Utah|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees||Huntsman Cancer Institute / Lisa Cannon-Albright, PhD||Innovation Grants||2012||Utah|
|Is SIRT5 a Therapy Target in Acute Lymphoblastic Leukemia?||University of Utah / Michael Deininger, MD/PhD||Innovation Grants||2018||Utah|